Bharat Biotech's Covaxin Approved by Germany
'Made in India' Bharat Biotech's COVID-19 vaccine Covaxin has been approved by Germany.
"The Federal Cabinet of Germany has approved Covaxin and relaxed restrictions on the entry for those vaccinated with WHO-approved vaccines. The promulgation takes effect from June 2022," said the vaccine manufacturer in a statement.
‘Covaxin has been approved by Germany. The entrants will no longer need proof of vaccination as the Federal Cabinet relaxes restrictions.’
Covaxin Approval: New Insights
Walter J. Lindner, German ambassador to India, on May 26th Thursday hailed the German government for recognizing the WHO-listed Bharat Biotech's Covid vaccine, Covaxin, for travel to the country starting June 1.Taking to Twitter, the Ambassador said: "Very happy that GER government just decided to recognize WHO-listed Covaxin for travels to GER, starting June 1! This Embassy has been pushing very actively for such decision (because of Covid-backlogs visa sections have longer waiting periods than normal, please have patience)."
The World Health Organization in November last year issued an emergency use listing (EUL) for Covaxin.
Source: IANS